Literature DB >> 20392196

Rapid alteration of stress-induced hypothalamic-pituitary-adrenal hormone secretion in the rat: a comparison of glucocorticoids and cannabinoids.

Abigail B Ginsberg1, Norman C Pecoraro, James P Warne, Hart F Horneman, Mary F Dallman.   

Abstract

The hypothalamic-pituitary-adrenal (HPA) axis self-regulates through a glucocorticoid negative feedback mechanism that is stereotypically slow and long lasting. Rapid (seconds to minutes) glucocorticoid feedback, however, inhibits stress-induced adrenocorticotropic hormone (ACTH) secretion too quickly to result from classic transcriptional effects of the occupied glucocorticoid receptor. Cannabinoids may act as rapid intermediary messengers between glucocorticoids and HPA activation via retroactive inhibition of afferent glutamate stimulation of the corticotropin-releasing factor neurons in the paraventricular nucleus. We demonstrated fast feedback effects of GR stimulation and blockade and observed the effect of cannabinoid receptor (CB1) antagonist AM251 on HPA axis reactivity in vivo. Rats were injected intraperitoneally with varying doses of the specific GR agonist RU28362, the GR antagonist RU486, or AM251 2 min before restraint. Blood was collected at predetermined times and corticosterone and ACTH concentrations were measured. RU28362 blunted stress-induced ACTH secretion while RU486 and AM251 significantly increased stress-induced ACTH release 15 min after restraint onset. Next, we injected AM251 58 min before RU28362, 2 min before restraint, to determine if inhibition of ACTH by RU28362 was contingent on CB1 activation. Unexpectedly, CB1 blockade failed to prevent glucocorticoid negative feedback and instead enhanced it. These studies not only establish an in vivo fast feedback model but show that rapid glucococorticoid negative feedback is similarly altered by GR and CB1 blockade. Although the hormonal consequences of acute AM251 treatment were strikingly similar to those of RU486 treatment, we are unable to draw conclusions about the serial nature of the interaction between GR activation and CB release from these results.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20392196     DOI: 10.3109/10253890903336839

Source DB:  PubMed          Journal:  Stress        ISSN: 1025-3890            Impact factor:   3.493


  12 in total

1.  Cannabinoid receptor type 1 antagonism significantly modulates basal and loud noise induced neural and hypothalamic-pituitary-adrenal axis responses in male Sprague-Dawley rats.

Authors:  R J Newsom; C Osterlund; C V Masini; H E Day; R L Spencer; S Campeau
Journal:  Neuroscience       Date:  2011-11-28       Impact factor: 3.590

2.  Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling.

Authors:  Nathan K Evanson; Jeffrey G Tasker; Matthew N Hill; Cecilia J Hillard; James P Herman
Journal:  Endocrinology       Date:  2010-08-11       Impact factor: 4.736

3.  Neural Regulation of the Stress Response: The Many Faces of Feedback.

Authors:  Brent Myers; Jessica M McKlveen; James P Herman
Journal:  Cell Mol Neurobiol       Date:  2012-02-01       Impact factor: 5.046

Review 4.  Neurobiological Interactions Between Stress and the Endocannabinoid System.

Authors:  Maria Morena; Sachin Patel; Jaideep S Bains; Matthew N Hill
Journal:  Neuropsychopharmacology       Date:  2015-06-12       Impact factor: 7.853

5.  Mechanisms of rapid glucocorticoid feedback inhibition of the hypothalamic-pituitary-adrenal axis.

Authors:  Jeffrey G Tasker; James P Herman
Journal:  Stress       Date:  2011-07       Impact factor: 3.493

6.  Inhibitory effects of corticosterone in the hypothalamic paraventricular nucleus (PVN) on stress-induced adrenocorticotrophic hormone secretion and gene expression in the PVN and anterior pituitary.

Authors:  M J Weiser; C Osterlund; R L Spencer
Journal:  J Neuroendocrinol       Date:  2011-12       Impact factor: 3.627

7.  Rapid Glucocorticoid Feedback Inhibition of ACTH Secretion Involves Ligand-Dependent Membrane Association of Glucocorticoid Receptors.

Authors:  Qiong Deng; Denise Riquelme; Loc Trinh; Malcolm J Low; Melanija Tomić; Stanko Stojilkovic; Greti Aguilera
Journal:  Endocrinology       Date:  2015-06-29       Impact factor: 4.736

Review 8.  Novel aspects of glucocorticoid actions.

Authors:  E T Uchoa; G Aguilera; J P Herman; J L Fiedler; T Deak; M B C de Sousa
Journal:  J Neuroendocrinol       Date:  2014-09       Impact factor: 3.627

9.  Remote CB1 receptor antagonist administration reveals multiple sites of tonic and phasic endocannabinoid neuroendocrine regulation.

Authors:  R J Newsom; R J Garcia; J Stafford; C Osterlund; C E O'Neill; H E W Day; S Campeau
Journal:  Psychoneuroendocrinology       Date:  2019-12-19       Impact factor: 4.905

Review 10.  Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis.

Authors:  Torsten Lowin; Rainer H Straub
Journal:  Arthritis Res Ther       Date:  2015-09-06       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.